Dr. Ignacio Duran titled his discussion of abstracts 2595MO, 2600MO, 2610MO: Bringing any clarity into the non-clear or ...

Theranostics and radiopharmaceutical therapies are rapidly transforming the medical landscape, and the neuro-oncology community is observing these developments with great interest. In a field characte ...

Scientists have built a “microwave brain” chip that processes information at radar-like speeds while sipping power. It could revolutionize how AI and communication devices operate, from smartwatches ...

With only $41 million in cash, Tvardi Therapeutics may need to raise additional funds within a one-year period. Click here to ...

Analytics in baseball presents an easy debate during the MLB playoffs: data vs. gut feel. But the two aren't at odds with ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of ...

Crawford, a medical oncologist at Duke Cancer Center and Duke Cancer Center Thoracic Clinic in Durham, North Carolina, ...

(Head of Commercial: Mike Petroutsas, "Astellas") today announced final overall survival (OS) results from the Phase 3 EMBARK study evaluating XTANDI ® (enzalutamide), in combination with leuprolide ...

Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company") today announced that it has completed its purchase of the Haywood quarry industrial and ...

It has been a busy and largely productive week for small-cap miners, leaving investors slightly more satisfied with their lot ...

Plain-language summary: Hemostemix will officially apply for ethics approval to begin a new clinical trial testing its ACP-01 stem-cell therapy in people with severe chest pain (angina) who no longer ...

Introduction Therapeutic exercise has been used to improve cancer-related dysfunction. Recent studies suggest that exercise ...